Get Your Personalized Supplement StackSupplement Stack Quiz

Inositol Nf

Also known as: Inositol, myo-inositol, MI, D-chiro-inositol

Overview

Inositol refers to a group of stereoisomers of cyclohexanehexol, with myo-inositol being the most biologically active form. It is a naturally occurring carbohydrate found in various foods like fruits, beans, grains, and nuts, and is also synthesized in the human body. As a supplement, inositol is commonly used to support metabolic and reproductive health, particularly in conditions such as Polycystic Ovary Syndrome (PCOS), infertility, gestational diabetes, and metabolic syndrome. It functions as a precursor for secondary messengers involved in insulin signal transduction and ovarian function. Research on inositol is mature, with numerous randomized controlled trials (RCTs) and systematic reviews/meta-analyses demonstrating its efficacy and safety. The available evidence is high-quality, especially in the context of PCOS and reproductive health.

Benefits

Inositol supplementation, particularly myo-inositol, has several evidence-based benefits. In women with PCOS, it improves hormonal profiles, reduces hirsutism, and normalizes the LH/FSH ratio. A meta-analysis showed a significant reduction in hirsutism and LH/FSH ratio when combined with metformin versus metformin alone. Inositol also has a modest but statistically significant effect on reducing BMI in various populations. For women undergoing IVF, myo-inositol supplementation improves ovarian response and IVF outcomes, including increased oocyte quality and pregnancy rates. Furthermore, inositol supplementation during pregnancy reduces the incidence of gestational diabetes and improves glucose metabolism. Improvements in insulin sensitivity, lipid profiles, and metabolic syndrome markers have also been reported.

How it works

Inositol primarily functions as a precursor for inositol phosphates and phosphatidylinositol, which are crucial for insulin signal transduction and intracellular calcium release. It modulates endocrine function, particularly in ovarian theca and granulosa cells, and enhances insulin sensitivity in peripheral tissues. The primary molecular targets include insulin receptor signaling pathways, gonadotropin signaling, and second messenger systems. Oral inositol, especially myo-inositol, is well-absorbed with good bioavailability, allowing it to effectively influence these biological pathways and improve metabolic and reproductive health.

Side effects

Inositol is generally recognized as safe with a favorable safety profile. The most common side effects, occurring in more than 5% of users, are mild gastrointestinal discomfort, such as nausea and diarrhea. Uncommon side effects, affecting 1-5% of individuals, include headache and dizziness. Serious adverse events are rare, with no significant issues reported in high-quality studies. There are no significant drug interactions reported, but caution is advised when combined with insulin or hypoglycemic agents due to the potential for additive effects on blood sugar levels. There are no well-established contraindications, but caution is recommended during pregnancy unless under medical supervision. Inositol has been widely studied in pregnant women without major safety concerns.

Dosage

The minimum effective dose of myo-inositol is typically 2 grams per day for PCOS and metabolic effects. Optimal dosage ranges are between 2 and 4 grams per day for reproductive and metabolic benefits. While doses up to 12 grams per day have been reported as safe in some studies, higher doses may increase the risk of gastrointestinal side effects. It is often recommended to split the daily dose into two administrations for better tolerance. Myo-inositol is the preferred form, and it is sometimes combined with D-chiro-inositol in a 40:1 ratio for PCOS. Taking inositol with meals may help reduce gastrointestinal discomfort. It is sometimes combined with folic acid or metformin for synergistic effects.

FAQs

Is inositol safe during pregnancy?

Yes, inositol is considered safe during pregnancy, particularly for gestational diabetes prevention, with substantial safety data supporting its use.

How long before benefits appear?

Improvements in hormonal and metabolic parameters typically manifest within 8–12 weeks of consistent inositol supplementation.

Can inositol replace metformin in PCOS?

Inositol can be a complementary or alternative treatment to metformin in some PCOS cases, but it is not a direct replacement and should be discussed with a healthcare provider.

Is there a difference between myo-inositol and D-chiro-inositol?

Yes, myo-inositol is more abundant and primarily used, while D-chiro-inositol has distinct but complementary roles in insulin signaling and ovarian function.

Research Sources

https://pubmed.ncbi.nlm.nih.gov/38163998/ – This systematic review and meta-analysis evaluated inositol's role in PCOS management, finding significant improvements in ovulatory function and metabolic parameters. The study included multiple RCTs, but limitations included heterogeneity in dosing and study populations. Overall, the evidence supports inositol's efficacy in managing PCOS.
https://pmc.ncbi.nlm.nih.gov/articles/PMC9159559/ – This systematic review and meta-analysis assessed inositol's effect on BMI, revealing a modest but statistically significant reduction. The analysis included subgroup and meta-regression analyses to explore heterogeneity, with studies generally having low to moderate risk of bias. The sample sizes were adequate, supporting the findings.
https://www.mdpi.com/2072-6643/14/14/2831 – This study likely contains information about inositol, but without a specific summary provided in the research content, a detailed summary cannot be generated. Please provide a summary of the article to fulfill this requirement.
https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1520362/full – This meta-analysis evaluated myo-inositol supplementation in women undergoing IVF, including those with mixed ovarian response. The study found improved oocyte quality and higher pregnancy rates. The methodology included Cochrane risk of bias assessment and sensitivity analyses, addressing moderate heterogeneity with appropriate statistical models.
https://academic.oup.com/jes/article/8/Supplement_1/bvae163.1580/7812114 – This meta-analysis compared metformin with and without myo-inositol in PCOS patients, including 4 RCTs with 277 participants. The addition of myo-inositol to metformin significantly reduced hirsutism and LH/FSH ratio compared to metformin alone. The study was limited by a small sample size but employed rigorous methodology.